As market demand continues to rise for
more effective and potent therapeutics,
drug developers are identifying novel
disease targets and biological mechanisms
for which medicines can be developed.
As a consequence, biologic pipelines are
evolving from standard antibody formats
to new molecular formats. Now more than
ever before, there is a real need for proven
and scalable expression platforms that
can keep pace with the requirements
of these proteins.
With more than 35 years of experience in
developing mammalian expression technologies
that underpin our development
and manufacturing services, we are ideally
placed to supply you with a robust and
versatile expression platform to optimize
production of your biotherapeutic.